Overview

A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease

Status:
Terminated
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Daikenchuto(TU-100)is effective in the treatment of Crohn's disease.
Phase:
Phase 2
Details
Lead Sponsor:
Tsumura USA
Collaborators:
INC Research
Syneos Health